Both in vivo and in vitro studies demonstrated that AF inhibited the HIF‐1 signaling pathway, thereby reducing microglial activation and associated inflammation, mitigating uric acid‐induced neuronal apoptosis, enhancing antioxidant defenses, and protecting neuronal function. The gene discussed is HIF1A; the disease is atrial fibrillation.